CLINICAL FINDINGS IN TRIAMCINOLONE-ASSOCIATED MACULOPATHY

Retina. 2019 Apr;39(4):761-765. doi: 10.1097/IAE.0000000000002007.

Abstract

Purpose: To describe a crystalline retinopathy observed in patients greater than 1 year after intravitreal injection of triamcinolone acetonide (IVTA).

Methods: A retrospective, interventional, noncomparative, single-center case series of patients who received IVTA and developed subsequent crystalline retinopathy lasting greater than 1 year after injection.

Results: Eighteen eyes of 16 patients in which preretinal crystals were observed >1 year after IVTA were included in the study, with a mean follow-up (range) of 5.8 years (1.1-9.2) after IVTA. The crystals were refractile, not visible on fluorescein nor indocyanine green angiography, exhibited slow dissolution and movement, and were occasionally distributed in a circular fashion. Optical coherence tomography confirmed the preretinal and/or subhyaloid location of crystals.

Conclusion: Macular crystals can persist for years after IVTA. The crystals localize to the preretinal or subhyaloid space, are angiographically silent, can exhibit slow dissolution and movement, may be distributed in a circular fashion reflecting the bursa premacularis, and appear nonpathologic.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Choroidal Neovascularization / drug therapy
  • Crystallization*
  • Diabetic Retinopathy / drug therapy
  • Female
  • Follow-Up Studies
  • Glucocorticoids / adverse effects*
  • Humans
  • Intravitreal Injections
  • Macular Edema / drug therapy
  • Male
  • Microscopy, Electron, Transmission
  • Middle Aged
  • Retina / drug effects*
  • Retina / ultrastructure
  • Retinal Diseases / chemically induced*
  • Retinal Diseases / diagnostic imaging
  • Retinal Vein Occlusion / drug therapy
  • Retrospective Studies
  • Tomography, Optical Coherence
  • Triamcinolone Acetonide / adverse effects*

Substances

  • Glucocorticoids
  • Triamcinolone Acetonide